» Articles » PMID: 22990084

State-transition Modeling: a Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3

Overview
Publisher Sage Publications
Date 2012 Sep 20
PMID 22990084
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

State-transition modeling (STM) is an intuitive, flexible, and transparent approach of computer-based decision-analytic modeling, including both Markov model cohort simulation as well as individual-based (first-order Monte Carlo) microsimulation. Conceptualizing a decision problem in terms of a set of (health) states and transitions among these states, STM is one of the most widespread modeling techniques in clinical decision analysis, health technology assessment, and health-economic evaluation. STMs have been used in many different populations and diseases, and their applications range from personalized health care strategies to public health programs. Most frequently, state-transition models are used in the evaluation of risk factor interventions, screening, diagnostic procedures, treatment strategies, and disease management programs.

Citing Articles

Changing Time Representation in Microsimulation Models.

Wong E, Isaranuwatchai W, Sale J, Tricco A, Straus S, Naimark D Med Decis Making. 2025; :272989X251319808.

PMID: 39995284 PMC: 11894904. DOI: 10.1177/0272989X251319808.


Modelling epidemiological and economics processes - the case of cervical cancer.

Taeger F, Mende L, Flessa S Health Econ Rev. 2025; 15(1):13.

PMID: 39985694 PMC: 11846406. DOI: 10.1186/s13561-024-00589-1.


Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force.

Botwright S, Sittimart M, Chavarina K, Bayani D, Merlin T, Surgey G Int J Technol Assess Health Care. 2025; 40(1):e74.

PMID: 39760423 PMC: 11703621. DOI: 10.1017/S0266462324004719.


US Tobacco 21 Policies and Potential Mortality Reductions by State.

Tam J, Crippen A, Friedman A, Jeon J, Colston D, Fleischer N JAMA Health Forum. 2024; 5(12):e244445.

PMID: 39705045 PMC: 11662258. DOI: 10.1001/jamahealthforum.2024.4445.


Using Joint Longitudinal and Time-to-Event Models to Improve the Parameterization of Chronic Disease Microsimulation Models: an Application to Cardiovascular Disease.

Giardina J, Haneuse S, Pandya A medRxiv. 2024; .

PMID: 39574877 PMC: 11581079. DOI: 10.1101/2024.10.27.24316240.